Have a feature idea you'd love to see implemented?
Let us know!
ZURA Zura Bio Ltd
Price (delayed)
$2.93
Market cap
$191.31M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.32
Enterprise value
$3.09M
zura bio is a clinical-stage biotechnology company advancing zb-168 in alopecia areata and other inflammatory diseases. zb-168 is an anti il7rα inhibitor that has the potential to impact diseases driven
Highlights
The company's equity has surged by 142% YoY but it fell by 2.2% QoQ
The EPS has soared by 100% year-on-year but it is down by 33% since the previous quarter
Key stats
What are the main financial stats of ZURA
Market
Valuations
Earnings
Shares outstanding
65.29M
Market cap
$191.31M
Enterprise value
$3.09M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.29
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$47.25M
EBITDA
-$47.25M
Free cash flow
-$21.34M
Per share
Balance sheet
Liquidity
EPS
-$0.32
Free cash flow per share
-$0.24
Book value per share
$2.28
Revenue per share
$0
TBVPS
$2.16
Total assets
$189.07M
Total liabilities
$18.24M
Debt
$0
Equity
$153.05M
Working capital
$170.73M
Debt to equity
0
Current ratio
10.36
Quick ratio
10.32
Net debt/EBITDA
3.98
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-29.9%
Return on equity
-39.7%
Return on invested capital
N/A
Return on capital employed
-27.7%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ZURA stock price
How has the Zura Bio stock price performed over time
Intraday
1.03%
1 week
-18.61%
1 month
-39.34%
1 year
-34.3%
YTD
-37.26%
QTD
-27.83%
Financial performance
How have Zura Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$50.28M
Net income
-$47.25M
Gross margin
N/A
Net margin
N/A
ZURA's net income is down by 36% since the previous quarter but it is up by 30% year-on-year
The operating income rose by 27% YoY but it fell by 22% QoQ
Growth
What is Zura Bio's growth rate over time
Valuation
What is Zura Bio stock price valuation
P/E
N/A
P/B
1.29
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 100% year-on-year but it is down by 33% since the previous quarter
The company's equity has surged by 142% YoY but it fell by 2.2% QoQ
The price to book (P/B) is 36% less than the last 4 quarters average of 2.0
Efficiency
How efficient is Zura Bio business performance
Zura Bio's ROE has soared by 85% YoY but it has decreased by 21% from the previous quarter
The return on assets has surged by 77% year-on-year but it has declined by 30% since the previous quarter
Dividends
What is ZURA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ZURA.
Financial health
How did Zura Bio financials performed over time
The total assets has soared by 81% YoY
The quick ratio has surged by 69% year-on-year but it has declined by 17% since the previous quarter
The debt is 100% smaller than the equity
The company's equity has surged by 142% YoY but it fell by 2.2% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.